Bakshi Chempharma Equipments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-07-2024
- Paid Up Capital ₹ 1.00 M
as on 31-07-2024
- Company Age 34 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 31-07-2024
- Satisfied Charges ₹ 5.09 Cr
as on 31-07-2024
- Revenue -19.83%
(FY 2023)
- Profit 92.50%
(FY 2023)
- Ebitda -34.35%
(FY 2023)
- Net Worth 27.57%
(FY 2023)
- Total Assets 28.00%
(FY 2023)
About Bakshi Chempharma Equipments
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.00 M. The company has closed loans amounting to ₹5.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Cawas Panthaki and Mahtab Panthaki serve as directors at the Company.
- CIN/LLPIN
U99999MH1990PTC055796
- Company No.
055796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bakshi Chempharma Equipments?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cawas Panthaki  | Director | 23-Sep-1993 | Current |
| Mahtab Panthaki | Director | 28-Mar-2013 | Current |
Financial Performance of Bakshi Chempharma Equipments.
Bakshi Chempharma Equipments Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.83% decrease. The company also saw a substantial improvement in profitability, with a 92.5% increase in profit. The company's net worth Soared by an impressive increase of 27.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bakshi Chempharma Equipments?
In 2023, Bakshi Chempharma Equipments had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bomex Machine Works Pvt LtdActive 38 years 3 months
Cawas Panthaki and Mahtab Panthaki are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tjsb Sahakari Bank Limited Creation Date: 30 Dec 2019 | ₹3.00 M | Open |
Tjsb Sahakari Bank Limited Creation Date: 05 Dec 2018 | ₹1.50 M | Satisfied |
The Thane Janata Sahakari Bank Ltd. Creation Date: 19 Jun 2008 | ₹3.50 M | Satisfied |
How Many Employees Work at Bakshi Chempharma Equipments?
Bakshi Chempharma Equipments has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bakshi Chempharma Equipments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bakshi Chempharma Equipments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
